Silicon Laboratories Inc (SLAB)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 26.70 | 9.33 | 10.37 | — | 14.34 | — | — | — | 7.33 | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | 13.67 | 39.13 | 35.20 | — | 25.46 | — | — | — | 49.78 | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 26.70
= 13.67
The days of sales outstanding (DSO) for Silicon Laboratories Inc have fluctuated over the past few quarters, indicating varying effectiveness in collecting accounts receivable.
As of Dec 31, 2023, the DSO stands at 13.67 days, showing an efficient collection process. This is a significant improvement from the previous quarter's DSO of 39.13 days, suggesting a possible focus on streamlining receivables management practices.
Looking back at the trend, the DSO has shown volatility, with peaks at 49.78 days (Dec 31, 2021) and 35.20 days (Jun 30, 2023), indicating potential challenges in collecting payments timely in those periods.
The absence of DSO data for some quarters suggests possible data reporting issues but also raises questions about the consistency and reliability of the company's accounts receivable management processes.
Overall, while the recent decline in DSO is a positive indicator, it is essential for Silicon Laboratories Inc to monitor and maintain efficient accounts receivable collection practices to ensure healthy cash flows and financial stability.
Peer comparison
Dec 31, 2023